| 531 |
IMPLANON NXT |
ETONOGESTREL 68 MG |
IMPLANT |
BLISTERPACK |
CONTRACEPTION |
Yes |
DKSH LAOS COMPANY LIMITED |
N.V.ORGANON |
NETHERLANDS |
CERTIFICATE RELEASED |
09 I 4018/14 |
2024-04-08 |
2027-04-07 |
View |
| 532 |
KADCYLA 100 MG |
TRASTUZUMAB EMTANSINE 106MG |
POWDER FOR INFUSION |
Vial |
METASTATIC BREAST CANCER |
No |
DKSH LAOS COMPANY LIMITED |
F. HOFFMANN - LA ROCHE LTD. |
SWITZERLAND |
CERTIFICATE RELEASED |
08 I 4774/19 |
2022-07-22 |
2025-07-21 |
View |
| 533 |
KADCYLA VIALS 160 MG |
TRASTUZUMAB EMTASINE 171 MG/VIALS |
POWDER FOR INFUSION |
VIAL |
METASTATIC BREAST CANCER |
No |
DKSH LAOS COMPANY LIMITED |
F. HOFFMANN-LA ROCHE AG |
SWITZERLAND |
CERTIFICATE RELEASED |
06 I 4716/19 |
2022-08-05 |
2025-08-04 |
View |
| 534 |
KETESSE |
DEXKETOPROFEN TROMETAMOL 36.90 MG EQ.TO DEXKETOPROFEN 25 MG |
FILM-COATED TABLETS |
ALU-BLISTER |
SYMPTOMATIC TREATMENT OF PAIN OF MILD TO MODERATE INTENSITY, SUCH AS MUSCULO-SKELETAL PAIN, DYSMENORROEA, DENTAL PAIN |
No |
DKSH LAOS COMPANY LIMITED |
A.MENARINI MANUFACTURING LOGISTICS AND SERVIC |
ITALY |
CERTIFICATE RELEASED |
04 I 4660/19 |
2022-08-23 |
2025-08-22 |
View |
| 535 |
KETOSTERIL |
TYROSINE 30 MG, HISTIDINE 38 MG, THREONINE 53 MG, TRYPTOPHAN 23 MG, LYSINE ACETATE 105 MG, CALCIUM-4-METHYL-2-OXO-VALERATE(KETO-ANALOGUE LEUCINE, CALCIUM SALT) 101 MG, CALCIUM -2-OXO-3-PHENYL-PROPIONATE (KETO-ANALOGUE PHENYLALANINE, CALCIUM SALT) 68 MG, CALCIUM-3-METHYL-2-OXO-BUTYRATE (KETO-ANALOGUE VALINE, CALCIUM SALT) 86 MG, CALCIUM-3-METHYL-2-OXO-VALERATE (KETO-ANALOGUE ISOLEUCINE, CALCIUM SALT) 67 MG, CALCIUM-DL-2-HYDROXY-4-METHYLTHIO-BUTYRATE (HYDROXY-ANALOGUE METHIONINE, CALCIUM SALT) 59 MG |
FILM COATED TABLET |
PLASTIC/ALU FOIL BLISTERPACK |
PREVENTION AND THERAPY OF DAMAGES DUE TO FAULTY OR DEFICIENT PROTEIN METABOLISM IN CHRONIC RENAL INSUFFICIENCY IN CONNECTION WITH LIMITED PROTEIN IN FOOD OF 40 G PER DAY (FOR ADULTS) AND LESS; I.E. GENERALLY IN PATIENTS WITH A GLOMERULAR FILTRATION RATE (GFR) BELOW 25 ML/MIN |
No |
DKSH LAOS COMPANY LIMITED |
LABESFAL-LABORATORIOS ALMIRO S.A. |
PORTUGAL |
CERTIFICATE RELEASED |
06 I 5542/23 |
2023-06-26 |
2026-06-25 |
View |
| 536 |
LATACOM |
EACH ML CONTAINS: LATANOPROST 0.05 MG, TIMOLOL MALEATE 6.83 MG |
EYE DROPS |
BOTTLE |
REDUCTION OF INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION WHO ARE INSUFFICIENT RESPONSIVE TO TOPICAL BETA BLOCKERS |
No |
DKSH LAOS COMPANY LIMITED |
DUOPHARMA (M) SDN BHD. |
MALAYSIA |
CERTIFICATE RELEASED |
01 I 5679/24 |
2024-02-06 |
2027-02-05 |
View |
| 537 |
LATANOST EYE DROPS 0.005 % |
LATANOPROST 0.0500 MG/ ML |
OPHTHALMIC SOLUTION |
BOTTLE |
FOR REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN-ANGLE GLAUCOMA, CHRONIC ANGLE CLOSURE GLAUCOMA AND OCULAR HYPERTENSION |
No |
DKSH LAOS COMPANY LIMITED |
DUOPHARMA (M) SDN BHD. |
MALAYSIA |
CERTIFICATE RELEASED |
06 I 5543/23 |
2023-06-26 |
2026-06-25 |
View |
| 538 |
LEDVIR |
LEDIPASVIR 90 MG, SOFOSBUVIR 400 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF CHRONIC HEPATITIS C IN ADULTS AND IN ADOLESCENT AGED 12 TO <18 YEARS. |
Yes |
DKSH LAOS COMPANY LIMITED |
MYLAN LABORATORIES LIMITED |
INDIA |
CERTIFICATE RELEASED |
12 I 5343/22 |
2022-12-30 |
2025-12-29 |
View |
| 539 |
LEVOFLOXACIN KABI |
LEVOFLOXACIN HEMIHYDRATE EQ.TO LEVOFLOXACIN 500 MG/100 ML |
SOLUTION FOR INFUSION |
BOTTLE |
COMMUNITY-ACQUIRED PNEUMONIA, COMPLICATED SKIN AND SOFT TISSUE INFECTION, ACUTE BACTERIAL SINUSITIS, ACUTE BACTERIAL EXACERBATION OF CHRONIC BRONCHITIS, CHRONIC BACTERIAL PROSTATITIS, PYELONEPHRITISAND COMPLICATED URINARY TRACT INFECTION, INHALATION ANTHRAX |
Yes |
DKSH LAOS COMPANY LIMITED |
FRESENIUS KABI VIETNAM JOINT STOCK COMPANY |
VIETNAM |
CERTIFICATE RELEASED |
04 I 5467/23 |
2023-04-11 |
2026-04-10 |
View |
| 540 |
LODOZ 2.5 MG/ 6.25 MG |
BISOPROLOL FUMARATE 2.50 MG, HYDROCHLOROTHIAZIDE 6.25 MG |
FILM COATED TABLET |
ALU-ALU BLISTER |
MILD TO MODERATE ESSENTIAL HYPERTENSION |
Yes |
DKSH LAOS COMPANY LIMITED |
MERCK HEALTHCARE KGaA |
FRANCE |
CERTIFICATE RELEASED |
12 I 5012/20 |
2024-04-08 |
2027-04-07 |
View |
